These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7193518)

  • 1. Renal handling of cis-diamminedichloroplatinum(II).
    Jacobs C; Kalman SM; Tretton M; Weiner MW
    Cancer Treat Rep; 1980; 64(12):1223-6. PubMed ID: 7193518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of cis-diamminedichloroplatinum secretion by the human kidney with probenecid.
    Jacobs C; Coleman CN; Rich L; Hirst K; Weiner MW
    Cancer Res; 1984 Aug; 44(8):3632-5. PubMed ID: 6540140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of cisplatin nephrotoxicity.
    Weiner MW; Jacobs C
    Fed Proc; 1983 Oct; 42(13):2974-8. PubMed ID: 6684595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal handling of cisplatin: interactions with organic anions and cations in the dog.
    Klein J; Bentur Y; Cheung D; Moselhy G; Koren G
    Clin Invest Med; 1991 Oct; 14(5):388-94. PubMed ID: 1742916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cis-diamminedichloroplatinum(II) after administration in hypertonic saline.
    Bajorin DF; Bosl GJ; Alcock NW; Niedzwiecki D; Gallina E; Shurgot B
    Cancer Res; 1986 Nov; 46(11):5969-72. PubMed ID: 3756934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of renal excretion of cisdichlorodiamine platinum.
    Caterson R; Etheredge S; Snitch P; Duggin G
    Res Commun Chem Pathol Pharmacol; 1983 Aug; 41(2):255-64. PubMed ID: 6685336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Change of creatinine clearance rate in accordance with aging in Japanese patients with head and neck cancer].
    Nishimura G; Horiuchi C; Yoshida T; Kawakami M; Yabuki K; Taguchi T; Nagao J; Kondo N; Masuda Y; Matsuda H; Mikami Y; Tsukuda M
    Gan To Kagaku Ryoho; 2006 Apr; 33(4):463-6. PubMed ID: 16612154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms for the renal secretion of cisplatin.
    Nelson JA; Santos G; Herbert BH
    Cancer Treat Rep; 1984 Jun; 68(6):849-53. PubMed ID: 6539649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma platinum levels: relationship to cisplatin dose and nephrotoxicity.
    Campbell AB; Kalman SM; Jacobs C
    Cancer Treat Rep; 1983 Feb; 67(2):169-72. PubMed ID: 6681731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution and disposition of platinum following intravenous administration of cis-diamminedichloroplatinum(II) (NSC 119875) to dogs.
    Litterst CL; Gram TE; Dedrick RL; Leroy AF; Guarino AM
    Cancer Res; 1976 Jul; 36(7 PT 1):2340-4. PubMed ID: 1277140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Assessment of kidney function before cisplatin administration: the need for 24-hour urine collection].
    Ptok M; Ptok A; Schwab M
    HNO; 1989 Feb; 37(2):67-70. PubMed ID: 2703375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time course of the binding of platinum to subfractions of the kidney cytosol in the cisplatin-treated rat.
    Mason R; Hogg S; Edwards IR
    Res Commun Chem Pathol Pharmacol; 1986 Apr; 52(1):51-8. PubMed ID: 3715197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platinum accumulation in the kidney and changes in creatinine clearance following chemotherapy with cisplatin in humans.
    Uozumi J; Ueda T; Yasumasu T; Koikawa Y; Naito S; Kumazawa J; Kamura T; Nakano H; Sueishi K
    Urol Int; 1993; 51(2):57-61. PubMed ID: 8351755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of renal clearance of cisplatin (cis-dichlorodiammine platinum ii) and its modification by furosemide and probenecid.
    Daley-Yates PT; McBrien DC
    Biochem Pharmacol; 1982 Jul; 31(13):2243-6. PubMed ID: 6889863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model independent pharmacokinetic study of cis-dichlorodiammineplatinum (II).
    Dumas M; d'Athis P; de Gislain C; Escousse A; Guerrin J; Autissier N
    Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):430-3. PubMed ID: 4044076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of para-aminobenzoic acid on the pharmacokinetics and urinary excretion of cis-diamminedichloroplatinum(II) in rats.
    Esposito M; Vannozzi M; Viale M; Pellecchia C; Civalleri D; Gogioso L
    Anticancer Res; 1995; 15(6B):2541-7. PubMed ID: 8669820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of concomitant administration of imatinib on cisplatin-induced nephrotoxicity focusing on renal organic cation transporter OCT2.
    Tanihara Y; Masuda S; Katsura T; Inui K
    Biochem Pharmacol; 2009 Nov; 78(9):1263-71. PubMed ID: 19540211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of probenecid and N'-methylnicotinamide on renal handling of cis-dichlorodiammineplatinum-II in rats.
    Osman NM; Litterst CL
    Cancer Lett; 1983 May; 19(1):107-11. PubMed ID: 6221790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic abnormalities associated with weight loss during chemoirradiation of head-and-neck cancer.
    Lin A; Jabbari S; Worden FP; Bradford CR; Chepeha DB; Teknos TN; Liao JJ; Nyquist GG; Tsien C; Schipper MJ; Urba S; Wolf GT; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1413-8. PubMed ID: 16109461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.